(Q53456749)

14 May 2018

title

Cancer risks in Crohn disease patients. (English)

1 reference

14 May 2018

0 references

K Hemminki

1

1 reference

14 May 2018

X Li

series ordinal

2

1 reference

14 May 2018

J Sundquist

series ordinal

3

1 reference

14 May 2018

K Sundquist

series ordinal

4

1 reference

14 May 2018

publication date

2 September 2008

1 reference

14 May 2018

published in

Annals of Oncology

1 reference

14 May 2018

volume

20

1 reference

14 May 2018

page(s)

574-580

1 reference

14 May 2018

issue

3

1 reference

14 May 2018

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

The risk of cancer in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Malignancy and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Risk of haematopoietic cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Cancer incidence before and after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Incidence of Cancer Among Patients With Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN595

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN595

1 reference

14 May 2018

PubMed ID

18765463

1 reference

14 May 2018